Diagnostic Approach and Management of Leukocytosis
Introduction to Leukocytosis
- The primary approach for a patient with leukocytosis should include a thorough evaluation for underlying causes, with immediate attention to hyperleukocytosis (WBC >100 × 10^9/L) which requires urgent treatment with hydroxyurea to prevent complications like tumor lysis syndrome, leukostasis, and organ damage 1
Diagnostic Evaluation
- Primary hematologic disorders such as acute myeloid leukemia (AML) and chronic myelogenous leukemia (CML) can cause leukocytosis 2, 3, 4
- Myeloproliferative neoplasms are also a cause of leukocytosis 5
Prognostic Factors
- Persistent leukocytosis >15 × 10^9/L is associated with poorer outcomes, particularly when accompanied by other signs of systemic inflammation 6
- Hyperleukocytosis (WBC >100 × 10^9/L) is a medical emergency associated with increased induction mortality due to hemorrhagic events, tumor lysis syndrome, and infections 1, 7
Management Approach
- Immediate cytoreduction with hydroxyurea at dosages up to 50-60 mg/kg/day until WBC is reduced to <10-20 × 10^9/L is recommended for hyperleukocytosis (WBC >100 × 10^9/L) 1
- Measures to prevent tumor lysis syndrome, including aggressive hydration, allopurinol or rasburicase to control uric acid production, and monitoring of urine pH, are crucial in managing hyperleukocytosis 1, 6, 7
- For suspected hematologic malignancy, obtaining bone marrow aspirate and biopsy for morphological examination, cytochemistry, immunophenotyping, and cytogenetic analysis is essential 2, 3
- HLA typing should be performed on patients who may be candidates for allogeneic stem cell transplantation, and risk stratification based on patient's age, initial leukocyte count, subtype classification, karyotype data, and medical history is necessary 2, 3, 7
Special Considerations
- Leukocytosis with ileus may indicate severe inflammatory response requiring more aggressive management, particularly in C. difficile infections 6